The cancer-testis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo
Open Access
- 28 August 2013
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 8 (5), 1549-1555
- https://doi.org/10.3892/mmr.2013.1659
Abstract
Cancer‑testis antigens (CTAs) are a group of tumor‑associated antigens restricted to male germ cells under normal physiological conditions. CTAs are expressed in certain types of tumors and thus are a novel target for immunotherapy. Nuclear RNA export factor 2 (NXF2) is a CTA of which the expression pattern, regulation and clinical significance are unclear. In the present study, following treatment with a demethylating agent, decitabine, NXF2 expression was detected in the majority of the NXF2‑negative acute leukemia cell lines, but not in healthy donor samples. This finding was confirmed by western blot analysis. Eight primary acute leukemia bone marrow samples were treated with decitabine in vitro, and results showed that NXF2 expression was significantly upregulated. In another nine acute myeloid leukemia or myelodysplastic syndrome patients, it was noted that the expression of NXF2 was upregulated in all patients following the first cycle of decitabine, which suggested that NXF2 was activated by decitabine treatment in vivo. Furthermore, NXF2 expression in acute leukemia cells was demonstrated to be regulated by CpG island hypermethylation. To the best of our knowledge, this is the first study to demonstrate that NXF2 is activated by demethylation in acute leukemia cells in vitro and in vivo. NXF2 may therefore serve as a novel target for immunotherapy against acute leukemia.Keywords
This publication has 22 references indexed in Scilit:
- A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyHaematologica, 2011
- High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsBlood, 2011
- Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast CancersPLOS ONE, 2011
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potentialMolecular Oncology, 2011
- Transgenic Expression of P1A Induced Thymic Tumor: A Role for Onco-Fetal Antigens in TumorigenesisPLOS ONE, 2010
- Inactivation of Nxf2 causes defects in male meiosis and age-dependent depletion of spermatogoniaDevelopmental Biology, 2009
- Is there a role for the nuclear export factor 2 gene in male infertility?Fertility and Sterility, 2008
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1New England Journal of Medicine, 2008
- NXF2 is involved in cytoplasmic mRNA dynamics through interactions with motor proteinsNucleic Acids Research, 2007
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991